AU2003264311A1 - Oral formulations of ibuprofen and tramadol, methods and preparation thereof - Google Patents

Oral formulations of ibuprofen and tramadol, methods and preparation thereof

Info

Publication number
AU2003264311A1
AU2003264311A1 AU2003264311A AU2003264311A AU2003264311A1 AU 2003264311 A1 AU2003264311 A1 AU 2003264311A1 AU 2003264311 A AU2003264311 A AU 2003264311A AU 2003264311 A AU2003264311 A AU 2003264311A AU 2003264311 A1 AU2003264311 A1 AU 2003264311A1
Authority
AU
Australia
Prior art keywords
tramadol
ibuprofen
preparation
methods
oral formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003264311A
Inventor
Jin Wang
Shuyi Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2003264311A1 publication Critical patent/AU2003264311A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2003264311A 2002-08-28 2003-08-25 Oral formulations of ibuprofen and tramadol, methods and preparation thereof Abandoned AU2003264311A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40645802P 2002-08-28 2002-08-28
US60/406,458 2002-08-28
PCT/CN2003/000713 WO2004026291A1 (en) 2002-08-28 2003-08-25 Oral formulations of ibuprofen and tramadol, methods and preparation thereof

Publications (1)

Publication Number Publication Date
AU2003264311A1 true AU2003264311A1 (en) 2004-04-08

Family

ID=32030629

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003264311A Abandoned AU2003264311A1 (en) 2002-08-28 2003-08-25 Oral formulations of ibuprofen and tramadol, methods and preparation thereof

Country Status (2)

Country Link
AU (1) AU2003264311A1 (en)
WO (1) WO2004026291A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2149546A1 (en) 2008-07-31 2010-02-03 Laboratorios Del. Dr. Esteve, S.A. Salts of tramadol and ibuprofen and their crystal form in the treatment of pain
AR073495A1 (en) * 2008-09-05 2010-11-10 Gruenenthal Gmbh PHARMACEUTICAL COMBINATION CONTAINING 6-DIMETHYLAMINOMETIL-1- (3-METOXI-PHENYL) -CICLOHEXANO-1,3-DIOL AND A NSAID
ES2356762B1 (en) * 2009-09-04 2011-11-24 Farmalider S.A. PHARMACEUTICAL COMPOSITION OF IBUPROFEN, TRAMADOL AND A BASIC AMINOACIDE, PROCEDURE FOR THE PREPARATION AND USE OF THE SAME.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU661723B2 (en) * 1991-10-30 1995-08-03 Mcneilab, Inc. Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug
ES2141688B1 (en) * 1998-11-06 2001-02-01 Vita Invest Sa NEW ESTERS DERIVED FROM SUBSTITUTED FENIL-CICLOHEXIL COMPOUNDS.

Also Published As

Publication number Publication date
WO2004026291A1 (en) 2004-04-01

Similar Documents

Publication Publication Date Title
AU2002363236A1 (en) Compounds, pharmaceutical compositions and methods of use therefor
AU2002337953A1 (en) Gentle-acting skin-disinfectants and hydroalcoholic gel formulations
AU2003248721A1 (en) Adsorbents, methods of preparation, and methods of use thereof
AU2003221683A1 (en) Thermal interface materials and methods for their preparation and use
AU2002332020A1 (en) Compositions for oral gene therapy and methods of using same
AU2003239614A1 (en) Cardiolipin compositions, methods of preparation and use
AU2003257550A1 (en) Soft capsule preparation
AU2003222347A1 (en) Novel peptide derivatives, preparation and therapeutic and cosmetic application thereof
AU2003220786A1 (en) Orodispersible pharmaceutical composition comprising agomelatine
AU2002320057A1 (en) Herbal composition for improving oral hygiene, and methods of using same
AU2003279911A1 (en) Therapeutic formulations
AU2003255645A1 (en) Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
AU2003249105A1 (en) Processes for the preparation of oral dosage formulations of modafinil
AU2003213345A1 (en) Cosmetic preparation
AU2003269018A1 (en) Acylaminothiazole derivatives, preparation and therapeutic use thereof
AU2003296369A1 (en) Imminoamines and preparation thereof
AU2003296469A1 (en) Dental compositions including enzymes and methods
AU2003217309A1 (en) Novel pyranosyl cytosines: pharmaceutical formulations and methods
AU2002359618A1 (en) Medicinal compositions and therapeutic methods
AU2003221532A1 (en) Combinations of epinastine, belladonna and pseudoephedrine as new pharmaceutical formulations
AU2003278604A1 (en) Oral preparation and chewing gum
AU2003264311A1 (en) Oral formulations of ibuprofen and tramadol, methods and preparation thereof
AU2003284942A1 (en) Oral extended release tablets and methods of making and using the same
AU2002244865A1 (en) Pharmaceutical composition of ibuprofen
AU2003230320A1 (en) Sustained release formulation of protein and preparation method thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase